CVM collaborators contribute to Accelerator Award for wound healing innovation
Article by: Allison Burk
Originally Published
Thomas Cherpes, DVM, MD, associate professor, and Rodolfo Vicetti Miguel, MD, assistant professor (research), both faculty members in Ohio State’s College of Medicine, Department of Otolaryngology – Head and Neck Surgery, have received an Ohio State University Accelerator Award for their project, “Towards commercialization of a novel peptide that accelerates cutaneous wound repair”.
These studies were supported by the College of Veterinary Medicine (CVM) through the Consortium for Advancement of Neuromusculoskeletal Science (NMS) and Locomotion (CANSL) and intramural equine awards.
The Accelerator Awards program provides funding to help translate Ohio State innovations into market-ready technologies through Ohio-based startup companies. Funded by the Ohio Third Frontier Technology Validation and Start-up Fund and Ohio State, the program is administered by the commercialization team at the Enterprise for Research, Innovation, and Knowledge.
Cherpes and Vicetti Miguel developed the peptide and demonstrated its ability to promote wound healing in mice. Follow-up studies in horses at Ohio State’s Galbreath Equine Center, conducted in collaboration with Hilary Rice, DVM, MS, DACVS-LA, and Caitlin Moreno, DVM, MS, DACVS-LA, both assistant professors in the Department of Veterinary Clinical Sciences, validated the peptide’s effectiveness in a clinically relevant setting. Rice also serves as the principal investigator for the CANSL award, and Moreno as the principal investigator for the equine intramural award.
“We’re excited to take this next step toward bringing a promising wound healing therapeutic to veterinary markets,” said Cherpes. “Our collaboration with Drs. Rice and Moreno is an exciting chance to bridge the gap between scientific discovery and real-world impact.”
The award will fund a comprehensive market assessment and regulatory landscape analysis to support the potential commercialization of their wound-healing technology.